153 related articles for article (PubMed ID: 30999302)
1. Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result.
Zhu X; Leof ER; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
Public Health Genomics; 2018; 21(3-4):154-163. PubMed ID: 30999302
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
Leof ER; Zhu X; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
Genet Med; 2019 Nov; 21(11):2468-2477. PubMed ID: 30992552
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
[TBL] [Abstract][Full Text] [Related]
4. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.
Christensen KD; Roberts JS; Shalowitz DI; Everett JN; Kim SY; Raskin L; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):522-9. PubMed ID: 21307304
[TBL] [Abstract][Full Text] [Related]
5. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
[TBL] [Abstract][Full Text] [Related]
6. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.
Peters MLB; Stobie L; Dudley B; Karloski E; Allen K; Speare V; Dolinsky JS; Tian Y; DeLeonardis K; Krejdovsky J; Button A; Lim C; Borazanci E; Brand R; Tung N
Cancer; 2019 Jul; 125(14):2488-2496. PubMed ID: 30980401
[TBL] [Abstract][Full Text] [Related]
7. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
8. Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.
Stump TK; Aspinwall LG; Kohlmann W; Champine M; Hauglid J; Wu YP; Scott E; Cassidy P; Leachman SA
J Genet Couns; 2018 Aug; 27(4):955-967. PubMed ID: 29349527
[TBL] [Abstract][Full Text] [Related]
9. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
[TBL] [Abstract][Full Text] [Related]
10. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
[TBL] [Abstract][Full Text] [Related]
11. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
[TBL] [Abstract][Full Text] [Related]
12. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
[TBL] [Abstract][Full Text] [Related]
13. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
[TBL] [Abstract][Full Text] [Related]
14. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
15. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
[TBL] [Abstract][Full Text] [Related]
16. Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers.
Christodoulou E; Visser M; Potjer TP; van der Stoep N; Rodríguez-Girondo M; van Doorn R; Gruis N
Fam Cancer; 2019 Oct; 18(4):439-444. PubMed ID: 31203567
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.
Stump TK; Aspinwall LG; Drummond DM; Taber JM; Kohlmann W; Champine M; Cassidy PB; Petrie T; Liley B; Leachman SA
Genet Med; 2020 Jan; 22(1):26-34. PubMed ID: 31371819
[TBL] [Abstract][Full Text] [Related]
18. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
Smith KR; West JA; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):385-92. PubMed ID: 10207644
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing in familial melanoma: uptake and implications.
de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
[TBL] [Abstract][Full Text] [Related]
20. Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Ringwald J; Wochnowski C; Bosse K; Giel KE; Schäffeler N; Zipfel S; Teufel M
J Genet Couns; 2016 Oct; 25(5):880-91. PubMed ID: 27074860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
